We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+6.73%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$7.04B
AUM Growth
+$449M
Cap. Flow
+$66.9M
Cap. Flow %
0.95%
Top 10 Hldgs %
69.19%
Holding
135
New
6
Increased
54
Reduced
51
Closed
9

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$52.2M
2
V icon
Visa
V
+$19.4M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$11.9M
4
META icon
Meta Platforms (Facebook)
META
+$11.3M
5
TMO icon
Thermo Fisher Scientific
TMO
+$11.1M

Top Sells

Rank Stock Value
1
HD icon
Home Depot
HD
+$37.6M
2
MDLZ icon
Mondelez International
MDLZ
+$11.6M
3
NKE icon
Nike
NKE
+$11.2M
4
CL icon
Colgate-Palmolive
CL
+$10.4M
5
CNC icon
Centene
CNC
+$9.46M

Sector Composition

Rank Sector Weight
1 Financials 27.87%
2 Healthcare 18.82%
3 Consumer Discretionary 16.92%
4 Communication Services 15.48%
5 Materials 6.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JAZZ icon
51
Jazz Pharmaceuticals
JAZZ
$16.1B
$7.3M 0.1%
49,951
-55,097
-52% -$8.33M
ESRX
52
DELISTED
Express Scripts Holding Company
ESRX
$7.24M 0.1%
114,268
+51,405
+82% +$3.19M
EXAS
53
DELISTED
Exact Sciences
EXAS
$7.21M 0.1%
153,130
-9,580
-6% -$386K
ZBH icon
54
Zimmer Biomet
ZBH
$18.6B
$6.98M 0.1%
+61,428
New +$7.09M
EXEL icon
55
Exelixis
EXEL
$14B
$6.9M 0.1%
284,588
-10,587
-4% -$282K
PTLA
56
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$6.63M 0.09%
122,801
+26,211
+27% +$1.54M
VTRS icon
57
Viatris
VTRS
$20.7B
$5.85M 0.08%
186,539
-8,100
-4% -$275K
VRTX icon
58
Vertex Pharmaceuticals
VRTX
$124B
$5.8M 0.08%
38,146
+32,146
+536% +$4.84M
TEVA icon
59
Teva Pharmaceuticals
TEVA
$39.1B
$5.74M 0.08%
326,269
+76,038
+30% +$1.71M
AIMT
60
DELISTED
Aimmune Therapeutics
AIMT
$5.72M 0.08%
230,900
-17,900
-7% -$386K
PODD icon
61
Insulet
PODD
$11.7B
$5.57M 0.08%
101,083
-5,982
-6% -$327K
SRPT icon
62
Sarepta Therapeutics
SRPT
$1.64B
$5.55M 0.08%
122,469
+941
+0.8% +$37.6K
NUVA
63
DELISTED
NuVasive, Inc.
NUVA
$5.26M 0.07%
+94,827
New +$6.27M
HZNP
64
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$4.86M 0.07%
383,148
-5,136
-1% -$65.3K
ONCE
65
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$4.67M 0.07%
52,349
+68
+0.1% +$5.16K
NVCR icon
66
NovoCure
NVCR
$1.78B
$4.58M 0.07%
230,500
-43,100
-16% -$847K
CAH icon
67
Cardinal Health
CAH
$54.3B
$4.57M 0.07%
68,307
-3,075
-4% -$217K
XENT
68
DELISTED
Intersect ENT, Inc
XENT
$4.57M 0.07%
146,726
-1,272
-0.9% -$37.6K
AERI
69
DELISTED
Aerie Pharmaceuticals
AERI
$4.34M 0.06%
89,384
-165
-0.2% -$9K
KTWO
70
DELISTED
K2M Group Holdings, Inc
KTWO
$4.27M 0.06%
201,192
+17,615
+10% +$408K
RARE icon
71
Ultragenyx Pharmaceutical
RARE
$2.49B
$4.14M 0.06%
77,691
+764
+1% +$45.3K
DERM
72
DELISTED
Dermira, Inc.
DERM
$4.13M 0.06%
153,061
+32,246
+27% +$844K
TVRD
73
Tvardi Therapeutics
TVRD
$22.1M
$3.99M 0.06%
8,093
+3,509
+77% +$1.76M
ITCI
74
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3.82M 0.05%
242,156
+24,194
+11% +$355K
EGRX
75
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3.82M 0.05%
64,042
+15,301
+31% +$926K
1 2
3
4 5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q3 2017 Portfolio in Review

As of Q3 2017, C WorldWide Group held 135 positions worth $7.04B, up 6.8% from $6.59B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

C WorldWide Group's Q3 2017 filing shows 6 new, 54 increased, 51 reduced and 9 closed positions. Its largest new stake was Zimmer Biomet: 61,428 shares worth $6.98M. The largest sale was Home Depot, an estimated $37.6M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • C WorldWide Group's largest Q3 2017 buy was Zimmer Biomet: 61,428 shares worth $6.98M.
  • C WorldWide Group added most to Citigroup in Q3 2017, an estimated $52.2M increase.
  • C WorldWide Group's biggest Q3 2017 reduction was Home Depot, cutting an estimated $37.6M.
  • C WorldWide Group fully exited Nike in Q3 2017, selling an estimated $11.2M.
  • C WorldWide Group's ten largest holdings make up 69% of its $7.04B portfolio in Q3 2017.
  • C WorldWide Group opened 6 new positions and closed 9 in Q3 2017.
  • C WorldWide Group's portfolio value rose 6.8% quarter-over-quarter to $7.04B.

Based on C WorldWide Group's 13F filing for Q3 2017, filed 6 Nov 2017.